Skip to main content

Table 2 Treatment breaks among antifibrotic users (N = 130, missing 2)

From: Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries – a real-world study from Finland

Break (days)

Frequency, N (%)

 ≥ 45

36 (27.7%)

 ≥ 90

19 (14.6%)

 ≥ 120

14 (10.8%)

 ≥ 180

11 (8.5%)